Skip to main content
TipRanks
Go Ultimate75% OFF

Tenaya Therapeutics (TNYA) Drug Pipeline

3,506 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Tn-401Arrhythmogenic Right Ventricular CardiomyopathyPhase IRecruitingOpen-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVCJan 18, 2024―
Tn-201Hypertrophic Cardiomyopathyphase1AndPhase2RecruitingMulti-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCMApr 18, 2023―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Tenaya Therapeutics, Inc. (TNYA) have in its pipeline
Tenaya Therapeutics TNYA is currently developing the following drugs: Tn-401, Tn-201. These drug candidates are in various stages of clinical development as the company works toward FDA approval.